Korea Hot Sale PLA Skin Booster Lenisna 200mg G Poly Lactic Acid 170mg Hyaluronic Acid 30mg CE FDA Collagen Regeneration Anti Aging Injection Filler

• Application: Cosmetic Surgery Center
• Disposable: Disposable
• Gender: Unisex
• Side Effect: No
• Usage: Injection
• Pharmaceutical Technology: Chemical Synthesis
• Model NO.: Lenisna 200mg
• Efficacy: Wrinkle Removal & Skin Beauty
• Shelf Life: 2years
• Function: Remove Wrinkle, Skin Tightening
• Treatment Cycle: Single Treatment Can Be Performed Again After 3 Mo
• Feature: Anti-Aging, Anti-Wrinkle
• Transport Package: Carton with Foam
• Specification: 200mg(plla+ha)5ml
• Trademark: Lenisna
• Origin: Korea
• HS Code: 3506100090
• Production Capacity: 1000000 Boxes/Year

Product Description

Product Description

NO LUMPS, NO MASSAGING

LENISNA is a hybrid filler which have connected both benefits of immediate filling efect of HA (hyaluronic acid) and long-term stimulation of collagen production by  PDLLA (Poly D,L - lactide).

 

What is LENISNA?

What makes LENISNA unique?

Indications

The effects of therapy

Injection methods

 

HOW LENISNA WORKS?

1. PHYSICAL SUPPORT

DAY 1.

Immediately after injection, LENISNA particles locate and immediately fill the wrinkled areas with HA material. Meanwhile, PDLLA microparticles prevent the HA hydrogel from moving out of the area of action, adding cohesiveness due to its properties.

2. RESTORATION

AFTER 1 MONTH

After a month, when HA begins to hydrolyze, PDLLA microparticles support collagen production and improve skin elasticity. From this turning point, an advantage in the action of PDLLA begins, resulting in long-term collagen production.

3. MAINTENANCE

6. MONTH

After 6 months, you can see the final result of using LENISNA. The product has been gradually biodegradable and restored the skin's volume from physical stabilization to newly synthesized collagen fibers that maintain the natural effect over time.

STAGES OF THE TREATMENT

MIXING OF THE PREPARATION

Add 5 ml of sterile water for injection to the vial. Place the preparation in a VORTEX laboratory shaker. After 30 minutes, the preparation is ready for use.

ANESTHESIA

In the case of injection of the preparation with a cannula, a specialist performs anesthesia of the injection site

PERFORMANCE OF THE TREATMENT

Performing the procedure with a needle or cannula

DIFFERENCES IN LACTIC ACID

IN THE FORM OF PDLLA AND REGULAR PLLA

Spherical mesh structure

PDLLA (LENISNA) microparticle

VS

Broken glass structure

PLLA microparticle

 

Porous spherical structure

PDLLA (LENISNA) microparticle

VS

Broken glass structure

PLLA microparticle

FEATURES AND BENEFITS OF USING LENISNA

• the only hybrid formula in the world Poly D, L Lactide + HA with particle size from 50 to 60 micrometers
• effectiveness and safety confirmed by clinical trials
• durability of effects - over 2 years from the last treatment
• immediate effect - due to hyaluronic acid
• safety - FDA and CE certificates for polylactic acid
• patents and own clinical trials
• particle size from 50 to 60 microns
• comfort of the procedure - easy injection and no needle clogging during the procedure

The product is designed as a time-acting filler with 170 mg of PDLLA  , and 30 mg of uncross-linked hyaluronic acid.

Lenisna  is a hybrid filler which have connected both benefits of immediate filling efect of HA (hyaluronic acid) and long-term stimulation of collagen production by  PDLLA (Poly D,L - lactide).



Lenisna Indications:

Due to the high concentration of poly D,L lactic acid - 170 mg and hyaluronic acid - 30 mg, the treatment is intended for people:

with clear signs of aging 40 +
needing to increase the volume of sunken areas of the face
especially for the correction of skin depressions such as: folds in the skin, wrinkles, furrows, as well as in the case of face drooping and skin laxity
Lenisna Effects:

The effects of the therapy are visible immediately after administration. We obtain a filling effect thanks to the presence of hyaluronic acid. After about 2 weeks, the production of collagen is initiated by the presence of PDLLA lactic acid microparticles. The effects of the therapy last for over two years after the last treatment. The recommended number of treatments is 2 or 3, depending on the skin deficiency, at intervals of 6-8 weeks. After two years it is recommended to carry out 1 reminder treatment.

Method:

the preparation in the amount of 5 ml is administered with the use of a thin cannula of 22 to 25 G size or needles of 25-26 G size
it is applied to the subcutaneous or periosteal tissue
Ingredients:

170 mg PDLLA
30 mg  HA
This pack consists of:

1 Vial: 5 ml

CE certified

PRODUCT PREPARATION:

Add 5 ml of sterile water for injection to the vial. The preparation is placed in a VORTEX laboratory shaker. After 30 minutes, the preparation is ready for use.

Remarss company covers an area of 35000 square meters,of which the purification workshop is 8000 square meters.
The company has independent research and development of Beijing university of more than 50 sets of advanced modern machinery and equipment, 
such as agnail cutting machine, automatic group installed, blister packing machine and so on.We also have more than 10 quality inspection personnel and 150 employees trained.
The annual production capacity of pdo thread and hyaluronic acid company is 5 million pieces.